Dow Up 0.12% Nasdaq Up 1.35%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
7.07 0.24(3.51%) Oct 20, 4:00PM EDT
Prev Close:6.83
Open:6.80
Bid:7.08 x 700
Ask:7.10 x 1300
1y Target Est:15.75
Beta:-0.520
Next Earnings Date:N/A
Day's Range:6.80 - 7.09
52wk Range:5.06 - 15.67
Volume:111,837
Avg Vol (3m):293,618
Market Cap:109.46M
P/E (ttm):N/A
EPS (ttm):-1.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CNATUp 3.51%109.46M
GALT111.54M
ICPT4.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.62
Quarterly EPS Est (Sep-14) :-0.44
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-4.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback